BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis C virus
1
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM | Browse: 29 | Download: 19
2
Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions
8/7/2019 7:09:17 AM | Browse: 30 | Download: 18
3
Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
6/6/2019 5:44:00 PM | Browse: 41 | Download: 47
4
Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
6/6/2019 8:31:40 AM | Browse: 40 | Download: 31
5
Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus co-infection in human immunodeficiency virus infected individuals
5/27/2019 8:24:36 AM | Browse: 41 | Download: 21
6
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 74 | Download: 42
7
Necrolytic acral erythema in a human immunodeficiency virus/hepatitis C virus coinfected patient: A case report
2/26/2019 11:29:06 AM | Browse: 103 | Download: 49
8
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 101 | Download: 28
9
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
1/7/2019 10:39:41 AM | Browse: 103 | Download: 41
10
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
12/27/2018 9:28:07 AM | Browse: 97 | Download: 43
11
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 148 | Download: 56
12
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 90 | Download: 49
13
Mononuclear phagocyte system in hepatitis C virus infection
11/27/2018 5:55:53 AM | Browse: 98 | Download: 48
14
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
11/7/2018 2:30:08 AM | Browse: 133 | Download: 56
15
Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
10/26/2018 11:38:21 AM | Browse: 101 | Download: 47
16
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 118 | Download: 56
17
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 152 | Download: 102
18
Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
9/27/2018 9:38:46 AM | Browse: 132 | Download: 64
19
Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study
9/14/2018 5:53:04 AM | Browse: 126 | Download: 52
20
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 187 | Download: 79
21
Form confers function: Case of the 3’X region of the hepatitis C virus genome
8/13/2018 7:45:11 AM | Browse: 119 | Download: 53
22
Hepatitis C and renal transplantation in era of new antiviral agents
8/9/2018 8:05:57 AM | Browse: 132 | Download: 49
23
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 218 | Download: 118
24
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
6/26/2018 12:26:34 AM | Browse: 179 | Download: 97
25
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 217 | Download: 113
26
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 250 | Download: 145
27
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 200 | Download: 97
28
Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release
3/26/2018 8:48:04 AM | Browse: 193 | Download: 79
29
Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
3/16/2018 12:27:25 PM | Browse: 234 | Download: 83
30
Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
3/4/2018 12:36:47 PM | Browse: 194 | Download: 62
31
Hepatitis C virus: Morphogenesis, infection and therapy
3/4/2018 12:36:47 PM | Browse: 256 | Download: 138
32
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
1/26/2018 8:09:36 AM | Browse: 261 | Download: 215
33
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 287 | Download: 157
34
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
1/19/2018 9:46:49 AM | Browse: 269 | Download: 84
35
Hepatitis C virus core protein-induced miR-93-5p inhibits IFN signaling pathway through targeting IFNAR1
1/14/2018 5:07:58 AM | Browse: 262 | Download: 147
36
Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas
1/7/2018 4:21:05 AM | Browse: 307 | Download: 183
37
Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet?
1/7/2018 4:21:04 AM | Browse: 246 | Download: 108
38
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 244 | Download: 95
39
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
12/12/2017 8:34:13 AM | Browse: 257 | Download: 108
40
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
11/24/2017 12:22:15 AM | Browse: 362 | Download: 183
41
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 391 | Download: 418
42
(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes
8/28/2017 6:54:48 AM | Browse: 283 | Download: 351
43
Lurking epidemic of hepatitis C virus infection in Iran: A call to action
8/25/2017 1:53:29 AM | Browse: 313 | Download: 181
44
Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
8/19/2017 11:33:53 AM | Browse: 215 | Download: 194
45
Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model
7/28/2017 8:16:18 AM | Browse: 255 | Download: 676
46
Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
7/17/2017 11:13:33 PM | Browse: 241 | Download: 257
47
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
7/5/2017 4:40:07 AM | Browse: 301 | Download: 361
48
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 630 | Download: 1390
49
Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients
5/12/2017 10:16:48 PM | Browse: 304 | Download: 489
50
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
4/13/2017 3:45:15 PM | Browse: 338 | Download: 501